
Keywords: NK, natural killer cells; PARs, protease-activated receptors; PAR1, protease-activated receptor type 1; PAR2, protease-activated receptor type 2; PAR3, protease-activated receptor type 3; PAR4, protease-activated receptor type 4; PBMC, peripheral blood mo